| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Centre for Computational Chemistry and School of Chemistry, University of Bristol, Bristol, BS8 1TS, United Kingdom
Correspondence: Address reprint requests and inquiries to Jeremy N. Harvey, Tel.: 44-0-117-954 6991; Fax: 44-0-117-925-1295; E-mail: jeremy.harvey{at}bristol.ac.uk.
| ABSTRACT |
|---|
|
|
|---|
The relationship between protein structure and function is central to biochemistry and can be usefully probed with model proteins such as myoglobin (Mb). Despite intensive experimental study, it is still unclear exactly how Mb's tertiary structure affects the geminate recombination of carbon monoxide (1
,2
). We are interested in examining this problem at an atomistic level by using a quantum mechanical (QM) description of the heme group with a simpler molecular mechanics (MM) treatment of the remaining Mb (QM/MM method) (2
). This allows us to treat the area of interest with accurate density functional theory while including effects from the rest of the protein. As a first step we report here our results concerning the thermochemistry of CO bonding in Mb, which highlight the presence of two functionally distinct allosteric states, corresponding to the tertiary structures of unligated Mb (deoxyMb, T) and CO-ligated Mb (MbCO, R). Such allosteric states are usually associated with multimeric proteins such as hemoglobin (Hb), where they allow cooperative binding of O2. Monomeric Mb is often considered to be nonallosteric but this view is changing (3
) based partly on how lactate reduces its O2 affinity (4
), differences in MbO2 and deoxyMb O2 equilibration curves (5
), and Mb's control of pseudoenzymatic reactions (6
).
Allosteric behavior in Mb is possible because ligand binding is accompanied by structural changes as Mb relaxes between ligated (R) and unligated (T) tertiary structures. This change in structure for Mb is similar, but not identical to that observed in the
- and ß-subunits of Hb (7
). As CO dissociates from the heme iron, the iron atom moves
0.3 Å out of the porphyrin plane and the heme distorts from planarity. Concerted motion of the rest of Mb, notably the E and F
-helices (8
,9
), completes the transition between the T and R states. The impact of this relaxation on ligand binding is not yet fully understood.
We have explored the effect of Mb's tertiary structure on CO geminate reactivity by using QM/MM methods to calculate Fe-CO binding enthalpies. This has allowed us to probe Mb's allostery and to test our QM/MM methodology by comparing our bond energies to experiment (10
). Calculating accurate metalloprotein bond energies is challenging, especially when structural relaxation accompanies ligand binding. Properties and energies of proteins vary slightly as they fluctuate between multiple conformational substates (11
), within each tertiary state. We allowed for such variations and relaxation by calculating bond energies separately for Mb R and T states as averages of 11 values for different substates generated from molecular dynamics (MD) trajectory snapshots and minimized crystal structures. Previous QM/MM optimized geometries show that the Fe-CO bond is distorted
9° by Mb's tertiary structure and slightly stabilized by a very weak hydrogen bond between the distal histidine (His-64) and oxygen of bound CO (12
,13
). The energetic impact of structural relaxation upon binding was not addressed in these studies (12
,13
). Crystal studies reveal that relaxation from the T state to the R state enables Val-68 to move from a position where it blocks CO binding to a sterically more favorable orientation (8
). Such steric crowding in the distal cavity of T state Mb is verified here and helps explain Mb's allostery.
We started with 1.15-Å resolution x-ray structures of deoxyMb and MbCO (Protein Data Bank entries 1A6N and 1A6G (14
)), then removed waters of crystallization and sulfate ions. The CHARMM all-atom force field (15
) was modified by additional heme group parameters and used with CHARMM v27b2 (16
) to prepare both proteins and carry out MD simulations. Hydrogen atoms were added according to standard pKA values for all amino acids except histidines. His-64 was chosen as the N
-protonated tautomer, in agreement with converging opinion (12
,13
), and the protonation states of other histidines were assigned according to their hydrogen bonding environment. Each protein was solvated with a 9-Å layer of preequilibrated TIP3 water to create two systems of
10,000 atoms. Relaxation, heating to 300 K over 30 ps and equilibration until stable (
300 ps) prepared both systems for a 100-ps production run. No constraints or restraints were applied throughout. MM minimization of each solvated crystal structure and of 10 snapshots from each MD production run, generated 11 deoxyMb and 11 MbCO structures for QM/MM BDE calculations.
The Fe-CO BDE is the energy difference between MbCO and the sum of gas phase CO and deoxyMb, if both Mbs have a similar conformation. Convergence to the same local substate for MbCO and deoxyMb is essential to obtain meaningful values, and was achieved by creating deoxyMb and MbCO "pairs" then carrying out a series of iterations, as described by Wirstam et al. (17
) for O2 binding to hemethyrin. Eleven T-state "pairs" were created by addition of CO to deoxyMbs and 11 R-state "pairs" were made by removal of bound CO from MbCO. The QM/MM calculations used the Jaguar QM program (18
) and Tinker MM code (19
), coupled by our QM/MM routines (2
). The QM region, consisting of the heme porphine, the His-93 imidazole side chain and CO, were treated with the hybrid B3LYP functional and a flexible basis set. All other atoms made up the MM region, which was treated with the CHARMM all-atom force field (15
). All results include a correction for zero-point energy (ZPE) calculated for a gas-phase model. Full computational details are in the Supplementary Material.
The overall BDE of Fe-CO Mb (shown as
Eoverall in the thermodynamic cycle of Fig. 1) can be written in two different ways as a sum of two terms:
Eoverall =
E1 +
E2 or
E3 +
E4. One contribution is the average QM/MM bond energy for the R and T states of Mb (
E1 and
E3, respectively). The other contribution is the relaxation energy for interconversion of R and T states in deoxyMb or MbCO (
E2 or
E4, respectively). These cannot be readily calculated using our method. It is, however, apparent that
G2 is negative, and
G4 is positive, since MbCO and deoxyMb are known to adopt R and T states, respectively. Assuming that entropic effects are small for the free energies
G2 and
G4, we can therefore write that
E1 >
Eoverall >
E3. As a first approximation, we can take
Eoverall as the average of
E1 and
E3; the difference between these values provides an estimate of the effect of the tertiary structure on the bond energy.
|
E1 = 9.4 kcal/mol. The average for the T state is
E3 = 6.9 (range 3.09.0 kcal/mol). This yields an estimated BDE
Eoverall of 8.1 kcal/mol, in good agreement with the experimental value of 10.8 kcal/mol (10
E1 is 2.6 kcal/mol larger than
E3, showing that the two tertiary states are functionally different.
Structural analysis (Table S2 in Supplementary Material) reveals more steric hindrance in the distal cavity in the T state than in the R state. Distances between the CO oxygen and the hydrogen atoms Phe-43 CzH, His-64 N
2H, and Val-68 C
2H increase on average by 0.48, 0.53, and 0.05 Å during relaxation from the T to R. This does not, however, lead to significant changes in the tilt or bend of the Fe-CO bond (the Fe-C-O angle is
175° in both states), in agreement with the known rigidity of this moiety (13
). Increased amplitude of the motion of the iron into the heme plane upon CO binding lowers the BDE; this average movement is 0.33 Å for the T state and 0.25 Å for the R state. The polarizing effect of the protein environment on the QM region leads to an increase of 0.4 kcal/mol on average of the Fe-CO BDE (Table S3 in Supplementary Material). These electrostatic effects weakly destabilize the bond in the R state and weakly stabilize it in the T state, but the predominant contribution to the difference in bond energies between the two conformers is steric.
| SUPPLEMENTARY MATERIAL |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Submitted on November 18, 2005; accepted for publication December 13, 2005.
| REFERENCES |
|---|
|
|
|---|
2. Harvey, J. N. 2004. Spin-forbidden CO ligand recombination in myoglobin. Faraday Discuss. 127:165177.[CrossRef][Medline]
3. Frauenfelder, H., B. H. McMahon, R. H. Austin, K. Chu, and J. T. Groves. 2001. The role of structure, energy landscape, dynamics, and allostery in the enzymatic function of myoglobin. Proc. Natl. Acad. Sci. USA. 98:23702374.
4. Giardina, B., P. Ascenzi, M. E. Clementi, G. DeSanctis, M. Rizzi, and M. Coletta. 1996. Functional modulation by lactate of myoglobin: a monomeric allosteric hemoprotein. J. Biol. Chem. 271:1699917001.
5. Shibayama, N., and S. Saigo. 2003. Oxygen equilibrium properties of myoglobin locked in the liganded and unliganded conformations. J. Am. Chem. Soc. 125:37803783.[CrossRef][Medline]
6. Flogel, U., M. W. Merx, A. Godecke, U. K. M. Decking, and J. Schrader. 2001. Myoglobin: a scavenger of bioactive NO. Proc. Natl. Acad. Sci. USA. 98:735740.
7. Samuni, U., D. Dantsker, I. Khan, A. J. Friedman, E. Peterson, and J. M. Friedman. 2002. Spectroscopically and kinetically distinct conformational populations of sol-gel-encapsulated carbonmonoxy myoglobin: a comparison with hemoglobin. J. Biol. Chem. 277:2578325790.
8. Kachalova, G. S., A. N. Popov, and H. D. Bartunik. 1999. A steric mechanism for inhibition of CO binding to heme proteins. Science. 284:473476.
9. Srajer, V., Z. Ren, T. Y. Teng, M. Schmidt, T. Ursby, D. Bourgeois, C. Pradervand, W. Schildkamp, M. Wulff, and K. Moffat. 2001. Protein conformational relaxation and ligand migration in myoglobin: a nanosecond to millisecond molecular movie from time-resolved Laue X-ray diffraction. Biochemistry. 40:1380213815.[CrossRef][Medline]
10. Projahn, H. D., and R. Van Eldik. 1991. Volume profile analysis of the formation and dissociation of carboxymyoglobin: comparison with the corresponding oxymyoglobin system. Inorg. Chem. 30:32883293.[CrossRef]
11. Frauenfelder, H., S. G. Sligar, and P. G. Wolynes. 1991. The energy landscapes and motions of proteins. Science. 254:15981603.
12. Sigfridsson, E., and U. Ryde. 2002. Theoretical study of the discrimination between O2 and CO by myoglobin. J. Inorg. Biochem. 91:101115.[CrossRef][Medline]
13. Rovira, C., B. Schulze, M. Eichinger, J. D. Evanseck, and M. Parrinello. 2001. Influence of the heme pocket conformation on the structure and vibrations of the Fe-CO bond in myoglobin: a QM/MM density functional study. Biophys. J. 81:435445.
14. Vojtechovsky, J., K. Chu, J. Berendzen, R. M. Sweet, and I. Schlichting. 1999. Crystal structures of myoglobin-ligand complexes at near-atomic resolution. Biophys. J. 77:21532174.
15. MacKerell, A. D., D. Bashford, M. Bellott, R. L. Dunbrack, J. D. Evanseck, M. J. Field, S. Fischer, J. Gao, H. Guo, S. Ha, D. Joseph-McCarty, L. Kuchnir, et al. 1998. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B. 102:35863616.
16. Brooks, B. R., R. E. Bruccoleri, B. D. Olafson, D. J. States, S. Swaminathan, and M. Karplus. 1983. Charmm: a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4:187217.[CrossRef]
17. Wirstam, M., S. J. Lippard, and R. A. Friesner. 2003. Reversible dioxygen binding to hemerythrin. J. Am. Chem. Soc. 125:39803987.[CrossRef][Medline]
18. Schrodinger Inc. 19962001. Jaguar. Portland, OR.
19. Ponder, J. W. 2003. Tinker: Software Tools for Molecular Design. St. Louis, MO.
This article has been cited by other articles:
![]() |
A. Lodola, M. Mor, J. Zurek, G. Tarzia, D. Piomelli, J. N. Harvey, and A. J. Mulholland Conformational Effects in Enzyme Catalysis: Reaction via a High Energy Conformation in Fatty Acid Amide Hydrolase Biophys. J., January 15, 2007; 92(2): L20 - L22. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |